Autres langues Item 9 Labs Corp.

Actions

INLB

US46564C2035

Temps Différé OTC Markets Autres places de cotation 15:30:02 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,0001 ^USD	0,00 %		0,00 %	-94,74 %

2023	Article 9 Labs Corp. annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 juin 2023	CI
2023	Douglas Bowden démissionne de son poste de président du conseil d'administration d'Item 9 Labs Corp, à compter du 18 juillet 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Item 9 Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	21/08/23
Item 9 Labs : Bankruptcy - Form 8-K	20/07/23
Douglas Bowden Resigned as Chairman of the Board of Directors of Item 9 Labs Corp, Effective July 18, 2023	20/07/23
Douglas Bowden Resign as Interim CEO of Item 9 Labs Corp	20/07/23
Item 9 Labs Corp. Announces Resignation of Shane Evans as A Member of the Board of Directors	27/06/23
Item 9 Labs Corp. cancelled the acquisition of Sessions Cannabis from Steven Fry, Najla Guthrie, Darryl Allen, Louis Laskovski, 2628146 Ontario Ltd. and 11949896 Canada Inc.	25/05/23
Item 9 Labs Corp. Executes Major Restructuring to Pave the Way to Profitability	23/05/23
Item 9 Labs Corp. Announces Management Changes	23/05/23
Item 9 Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	22/05/23
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Change in Directors or Principal Officers, Other Events (form 8-K)	22/05/23
Item 9 Labs Corp. Announces Resignation of Michael Weinberger as Member of the Board of Directors	22/05/23
Item 9 Labs Corp. Announces CEO Changes	22/05/23
Item 9 Labs Corp. Announces the Resignation of Lawrence X. Taylor as Board of Director	12/05/23
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls	10/05/23
Item 9 Labs Releases Latest Limited Edition One-Gram Rosin-Infused Pre-Rolls	10/05/23
ITEM 9 LABS CORP. - 8-K - LABS CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)	05/05/23
Notice to the Annual General Meeting of MilDef Group AB (publ)	24/04/23
Unity Rd. To Exhibit at 2023 Multi-Unit Franchising Conference	13/04/23
Item 9 Labs Corp. To Present at the Benzinga Spring Cannabis Capital Conference	06/04/23
Item 9 Labs : Accelaration/Increase of Financial Obligation - Form 8-K	05/04/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Item 9 Labs Corp.

Actions

INLB

US46564C2035

Autres langues

Filtres